REQUEST A DEMO
Total
USD $0.00
Search more companies

Lavet Kft. (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing
Secondary Activities: Pharmacies and Drug Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: LAVET Gyogyszeripari Kft. Profile Updated: September 11, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Hungarian Download a sample report

LAVET Gyogyszeripari Kft. is a Hungarian pharmacy company and has a dominant position in the European veterinary market. The company has been incorporated in 1991 and its headquartered in the city of Budapest. The company’s activities include - development, manufacture and distribution of medicinal products. Lavet Kft. specializes mainly in producing of: anthelmintic, anti-inflammatory drugs, dietary supplements, and other cardiovascular agents.

Headquarters
Batthyany utca 6.
Kistarcsa; Pest; Postal Code: 2143

Contact Details: Purchase the Lavet Kft. report to view the information.

Website: http://www.lavet.hu

Basic Information
Total Employees:
Purchase the Lavet Kft. report to view the information.
Registered Capital:
Purchase the Lavet Kft. report to view the information.
Financial Auditors:
Purchase the Lavet Kft. report to view the information.
Incorporation Date:
December 05, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Zylavet Allatgyogyaszati Kft.
Company Performance
Financial values in the chart are available after Lavet Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
1.55%
Total operating revenue
-1%
Operating profit (EBIT)
-27.63%
EBITDA
-20.63%
Net Profit (Loss) for the Period
-27.42%
Total assets
9.45%
Total equity
13.81%
Operating Profit Margin (ROS)
-9.28%
Net Profit Margin
-9.05%
Return on Equity (ROE)
-8.06%
Quick Ratio
11.4%
Cash Ratio
9.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?